NADPH (tetracyclohexanamine)

NADPH tetracyclohexanamine functions as an important cofactor in a variety of metabolic and biosynthetic pathways. NADPH tetracyclohexanamine is an endogenous inhibitor of ferroptosis. NADPH tetracyclohexanamine plays a vital role in the biosynthesis of agents, chiral alcohols, fatty acids and biopolymers, while also being required for lipid biosynthesis, biomass formation, and cell replication[1][2][3][4].

100929-71-3

12352005

Endogenous Metabolite; Ferroptosis

Apoptosis; Metabolic Enzyme/Protease

Cancer; Metabolic Disease

99.86

DMSO : ≥ 84 mg/mL|H2O : ≥ 100 mg/mL

O[C@H]1[C@@H](O)[C@H](N2C=C(C(N)=O)CC=C2)O[C@@H]1COP(O)(OP(OC[C@@H]3[C@@H](O)[C@@H](OP(O)(O)=O)[C@H](N(C4=NC=N5)C=NC4=C5N)O3)(O)=O)=O.NC6CCCCC6.NC7CCCCC7.NC8CCCCC8.NC9CCCCC9

C45H82N11O17P3

1142.12

Room Temperature

4°C (Powder, sealed storage, away from moisture)

http://file.medchemexpress.com/batch_PDF/HY-F0003A/NADPH-tetracyclohexanamine-SDS-MedChemExpress.pdf

Oligonucleotides

No Development Reported

Human Endogenous Metabolite